ADVANCED PROTEOME THERAPEUTICS CORP

Profile

Company Names

ADVANCED PROTEOME THERAPEUTICS CORP

Addresses

104-8337 EASTLAKE DRIVE, BURNABY, A1 V5A 4W2

BIOSQUARE, 650 ALBANY STREET, SUITE 113, BOSTON, MA 02118

BIOSQUARE 650 ALBANY STREET, SUITE 113, BOSTON, MA 02118

BIOSQUARE 650 ALBANY STREET, SUITE 113, BOSTON, MA 02118

Phone Numbers

6048978025
617-638-0340

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

BRITISH COLUMBIA, CANADA

Total Amount Raised:

$2,535,372.00

Number of Funding Rounds:

9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2020-05-19 
$127,151.00 
$342,286.00 
$215,135.00 
Equity 
8
2018-08-22 
$15,365.00 
$38,414.00 
$23,049.00 
Equity 
7
2016-10-28 
$97,500.00 
$450,000.00 
$352,500.00 
Equity 
6
2016-05-19 
$217,406.00 
$217,406.00 
$0.00 
Equity 
5
2013-02-26 
$160,050.00 
$160,050.00 
$0.00 
Equity 
4
2013-02-04 
$690,000.00 
$690,000.00 
$0.00 
Equity 
3
2012-08-29 
$292,900.00 
$292,900.00 
$0.00 
Equity 
2
2012-02-21 
$35,000.00 
$35,000.00 
$0.00 
Debt 
1
2010-10-18 
$900,000.00 
$900,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEAN 
 
BELLIN 
DIRECTOR
ADVANCED PROTEOME THERAPEUTICS CORP
BEN 
 
CATALANO 
DIRECTOR
ADVANCED PROTEOME THERAPEUTICS CORP
RANDAL 
 
CHASE 
DIRECTOR
ADVANCED PROTEOME THERAPEUTICS CORP
WILLIAM JOHN (BILL) 
 
DICKIE 
EXECUTIVE OFFICER, DIRECTOR
ADVANCED PROTEOME THERAPEUTICS CORP
JOHN 
 
GARRETT 
DIRECTOR
TOMMIE COPPER INC.   |  COVERALL INSURANCE GROUP LLC   |  RELADYNE INC.   |  TOMMIE COPPER HOLDINGS, INC.   |  CHS HOLDING CORP   |  TAILWIND COLONY HOLDING CORP.   |  ADVANCED PROTEOME THERAPEUTICS CORP   |  GET WHYS INC.
GARY 
 
HAYES 
DIRECTOR
NATIVE AMERICAN BANCORPORATION CO   |  F-ORIGIN INC   |  ADVANCED PROTEOME THERAPEUTICS CORP
GARY 
W. 
HAYES 
DIRECTOR
ADVANCED PROTEOME THERAPEUTICS CORP
EDWARD 
KELLY 
HYSLOP 
DIRECTOR
ADVANCED PROTEOME THERAPEUTICS CORP
ALEXANDER 
 
KRANTZ 
EXECUTIVE OFFICER, DIRECTOR
ADVANCED PROTEOME THERAPEUTICS CORP   |  MISSION HILL HOSPITALITY TRUST II
ALEXANDER (ALLEN) 
 
KRANTZ 
EXECUTIVE OFFICER, DIRECTOR
ADVANCED PROTEOME THERAPEUTICS CORP
ALLEN 
 
KRANTZ 
EXECUTIVE OFFICER, DIRECTOR
ADVANCED PROTEOME THERAPEUTICS CORP
KEN 
 
PHILLIPPE 
EXECUTIVE OFFICER
DISCOVERY VENTURES INC.   |  MX GOLD CORP.   |  ADVANCED PROTEOME THERAPEUTICS CORP
KENNETH 
 
PHILLIPPE 
EXECUTIVE OFFICER
CONSTITUTION MINING CORP   |  ADVANCED PROTEOME THERAPEUTICS CORP   |  PHARMACIELO LTD.   |  GSP RESOURCE CORP.
MARTIN 
 
WOODWARD 
EXECUTIVE OFFICER, DIRECTOR
ADVANCED PROTEOME THERAPEUTICS CORP
PAUL 
 
WOODWARD 
DIRECTOR, EXECUTIVE OFFICER
CASSINI FUND, LP   |  ADVANCED PROTEOME THERAPEUTICS CORP   |  ADVANCED PROTEOME THERAPEUTICS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-05-26
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Equity 
2020-05-19 
2018-09-04
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Equity 
2018-08-22 
2016-11-03
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2016-10-28 
2016-05-25
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2016-05-19 
2013-02-28
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2013-02-26 
2013-02-14
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2013-02-04 
2012-09-11
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2012-08-29 
2012-03-02
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2012-02-21 
2010-11-08
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2010-10-18 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#